Melanoma vaccine: long-lasting anti-tumour response in patients
Four years after patients with melanoma were treated with a personalised cancer vaccine, the immune…
Browsing: NeoVax
Personal neoantigen vaccine prompts strong anti-tumour response in melanoma patients
A personal cancer treatment vaccine that targets distinctive “neoantigens” on tumour cells has been shown…